期刊文献+

HPLC法测定盐酸阿考替胺原料药的含量

Determination of acotiamide hydrochloridetrihydrate API content by HPLC
在线阅读 下载PDF
导出
摘要 为了建立一种盐酸阿考替胺原料药含量的测定方法,采用高效液相色谱法(HPLC),使用Agilent ZORBAX SB-C18色谱柱(25 cm×4.6 mm,5μm);柱温:30℃;检测波长:230nm;流速:1.0 m L/min;进样量:20μL;流动相:缓冲液(0.02 mol/L磷酸氢二钠加0.1%三乙胺溶液,稀磷酸调节pH值至3.0)∶乙腈=65∶35;稀释剂:流动相。结果表明,专属性研究结果显示盐酸阿考替胺保留时间为5.45 min,运行平稳,无杂质干扰;盐酸阿考替胺在0.20~0.60 mg/m L的浓度下,线性方程y=58.947x-0.201 7 (r2=0.999 7),线性关系良好;检测限为0.121μg/mL,定量限为0.452μg/mL;溶液稳定性试验证明供试品溶液24 h内稳定性较好,RSD为0.23 (n=7);重复性与中间精密度试验结果的RSD分别为0.10%(n=6)与0.14(n=12),重复性与中间精密度良好;耐用性考察的试验结果相对保留时间的RSD为1.05%(n=9),含量测定的RSD为0.13%(n=9);3批自制样品含量测定结果分别为99.11%、99.16%、99.09%。该方法数据准确可靠、检测快速、灵敏度高、耐用性强,可用于测定盐酸阿考替胺原料药的含量。 In order to develop a method for the determination of the content of acetamide in hydrochloride.The High-performance liquid chromatography(HPLC)was used with an Agilent ZORBAX SB-C18 column(25 cm×4.6 mm,5μm)as the analytical column;column temperature:30℃;detection wavelength:230 nm;flow rate:1.0 mL/min;injection volume:20μL;mobile phase:buffer solution(0.02 mol/L sodium dihydrogen phosphate solution with 0.1%triethanolamine,diluted with dilute phosphoric acid to pH=3.0):acetonitrile=65∶35;diluent:mobile phase.Results show that acotiamide hydrochloride had a retention time of 5.45 min,ran smoothly,and there was no interference from impurities.Acotiamide Hydrochloride had a good linear relationship with a linear equation of y=58.947x-0.2017(r2=0.9997)at a concentration of 0.20~0.60 mg/mL.The detection limit was 0.121μg/mL,the quantitative limit was 0.452μg/mL;the stability test of the sample solution showed that the stability was good within 24 h,with an RSD of 0.23(n=7);the RSDs of repeatability and intermediate precision were 0.10%(n=6)and 0.14(n=12),respectively,indicating good repeatability and intermediate precision;the RSD of the durability test was 1.05%(n=9),and the RSD of the content determination was 0.13%(n=9);the content determination results of three self-prepared samples were 99.11%,99.16%,and 99.09%.
作者 董永广 Dong Yongguang(Hebei Jiheng Pharmaceutical Corporation Ltd.,Hengshui 053400,China)
出处 《煤炭与化工》 2025年第6期152-156,共5页 Coal and Chemical Industry
关键词 高效液相色谱法 盐酸阿考替胺 含量测定 high performance liquid chromatography acotiamide hydrochloride trihydrate content
  • 相关文献

参考文献8

二级参考文献47

  • 1练鸿振.必须大力加强精细化学品的分析测试工作[J].精细与专用化学品,2005,13(11):6-9. 被引量:6
  • 2Seto K, Sasaki T, Kstdunuma K, Kobayashi N, Tanaka K, Tack J. Acotiamide hydrochloride (Z-338), a novel prokinetic agent, restores delayed gastric emptying and feeding inhibition induced by restraint stress in rats [ J ]. Neurogastroenterol Motility, 2008, 20 ( 5 ) : 1051 - 1059.
  • 3Nakajima T, Nawata H, Ito Y. Z-338, a newly synth- etized carboxyamide derivative, stimulates gastric motility through enhancing the excitatory neurotrans- mission [ J . Journal of Smooth Muscle Research, 2000, 36(2) : 69-81.
  • 4Ogishima M, Kaibara M, Ueki S, Kurimoto T, Taniyama K. Z-338 facilitates acetylcholine release from enteric neurons due to blockade of muscarinic autoreceptors in guinea pig stomach [ J ]. The Journal of Pharmacology and Experimental Therapeutics, 2000, 294( 1 ):33-37.
  • 5Furuta S, Emiko K, Omata T, Sugimoto T, Kawabata Y, Yonezawa K, Wu X C, Kurimoto T. Drug-drug interactions of Z-338, a novel gastroprokinetic agent, with terfenadine, comparison with cisapride, and involvement of UGT1A9 and 1A8 in the human metabolism of Z-338 [ J ]. European Journal of Pharmacology, 2004, 497 (2) : 223 - 231.
  • 6Matsueda K, Hongo M, Tack J, Aoki H, Saito Y, Kato H. Clinical trial: Dose-dependent therapeutic efficacy of acotiamide hydrochloride ( Z-338 ) in patients with functional dyspepsia-lO0 mg t. i. d. is an optimal dosage [ J]. Neurogastroenterology & Motility, 2010, 22 ( 6 ) : 618-625.
  • 7Kawaehi M, Matsunaga Y, Tanaka T, Hori Y, ho K, Nagahama K, Ozaki T, Inoue N, Toda R, Yoshii K, Hirayama M, Kawabata Y, Takei M. Acotiamide hydrochloride (Z-338) enhances gastric motility and emptying by inhibiting aeetylcholinesterase activity in rats . European Journal of Pharmacology, 2011,666 (1 -3) : 218 -222.
  • 8Matsunaga Y, Tanaka T, Yoshinaga K, Ueki S, Hori Y, Eta R, Kawabata Y, Yoshii K, Yoshida K, Matsumura T. Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: Comparison with cisapride, itopride, and mosapride [ J]. Journal of Pharmacology and Experimental Therapeutics, 2011, 336 (3) : 791 -800.
  • 9Yoshii K, Hirayama M, Nakamura T, Toda R, Hase- gawa J, Takei M, Mera Y, Kawabata Y. Mechanism for distribution of acotiamide, a novel gastroprokinetic agent for the treatment of functional dyspepsia, in rat stomach [ J 1. Journal of Pharmaceutical Sciences, 2011, 100 ( 11 ) : 4965 - 4973.
  • 10Sorbera L A, Castaner J, Leeson P A. Z-338, treatment of non-ulcer dyspepsia [ J ]. Drugs of the Future, 2003, 28(1) : 26 -30.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部